Cancer-Associated Thrombosis: A New Light on an Old Story
Cancer-associated thrombosis (CAT) is a rising and significant phenomenon, becoming the second leading cause of death in cancer patients. Pathophysiology of CAT differs from thrombosis in the non-cancer population. There are additional risk factors for thrombosis specific to cancer including cancer...
Main Authors: | Sidrah Shah, Afroditi Karathanasi, Antonios Revythis, Evangelia Ioannidou, Stergios Boussios |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Diseases |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-9721/9/2/34 |
Similar Items
-
Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
by: Sven R. Olson, et al.
Published: (2019-07-01) -
Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
by: Zygimantas Zaboras, et al.
Published: (2024-01-01) -
Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
by: Corinne Frere, et al.
Published: (2019-01-01) -
Cancer-associated thrombosis during chemotherapy: treatment and prevention: A review
by: Irina A. Koroleva, et al.
Published: (2022-08-01) -
The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature
by: Petroula Nana, et al.
Published: (2021-09-01)